Tuesday, August 21, 2018
 
 
Company News: Page (1) of 1 - 01/31/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Women's Excellence Offers Bioidentical Hormones as a Natural Solution for Hormone Imbalance in Menopausal Women
 
(January 31, 2018)
Women's Excellence Offers Bioidentical Hormones as a Natural Solution for Hormone Imbalance in Menopausal Women

Menopause can be a confusing time of transition for women and each woman experiences menopause differently. Symptoms of menopause vary but the most common complaints include hot flashes, mood changes, vaginal dryness, fatigue, decreased sex drive, and difficulty sleeping. Every woman is unique, requires special attention paid to her needs, and no single medication or treatment works for every menopausal woman.

The highly skilled providers of Women's Excellence in Menopause evaluate each woman individually, assessing the patient's desires and needs, to develop a unique “formula" or treatment plan which may include the use of bioidentical hormones. According to Shannon Hill, MSN, CNP, nurse practitioner and menopausal counselor at Women's Excellence in Menopause, “We take the time to really listen to each woman's needs which helps us decide upon the best bioidentical product to help her feel better balanced. No two women are alike so each therapy is individualized. I personally enjoy the relationship I build with a patient in figuring out what works best for her."

Shannon Hill has received special training in bioidentical hormone (BIH) therapy and works primarily with University Compounding Pharmacy in Troy, Michigan. Shannon also sees women for weight management visits, micronutrient testing, as well as bone mineral density testing and counseling. Heather Martin, MSN, WHNP, has also received training in BIH therapy and conducts the same types of visits at the Clarkston, Michigan location.



Women's Excellence is the most comprehensive obstetric and gynecologic office in Michigan. Additionally, they specialize in menopause, weight control, bladder control, endometriosis, robotic surgery, oncology and midwifery services. Women's Excellence is committed to staying at the forefront of innovation with cutting edge technologies utilizing robotic surgery and minimally invasive surgical options when possible. The knowledgeable, compassionate physicians and healthcare providers of Women's Excellence focus on patient-centered processes to deliver the highest quality of care. They are affiliated with most insurances. They offer seamless medical record access via a state of the art patient portal and use the latest technology for record keeping and sharing, making the patient experience easier and more efficient. Women's Excellence is taking new patients and is conveniently located throughout southeastern Michigan in Birmingham, Lake Orion, Clarkston, Rochester, and West Bloomfield. For more information, visit http://www.WomensExcellence.com.

Read the full story at http://www.prweb.com/releases/2018/02/prweb15149389.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The global connected health device market is expected to reach an estimated $36.1 billion by 2023 and is forecast to grow at a CAGR of 21.1% from 2018 to 2023
  • Global Hemodialysis and Peritoneal Dialysis Market to Witness a CAGR of 5.9% during 2018-2024
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023

    Cancer
  • New ESMO Tumour DNA Scale Helps Match Patients with Cancer to Optimal Targeted Medicines
  • /R E P E A T -- Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution/
  • Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer
  • Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines